EPA and DHA Market, By Source (Fish Oil, Algal Oil, Krill Oil, and Others), By Form (Liquid, Capsules and Soft gels, Powder, and Others), By Application (Dietary Supplements, Food and Beverages, Pharmaceuticals, and Others), By Geography (North America, L

Global EPA and DHA market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 3.32 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032. Global EPA and DHA market has been witnessing significant growth due to rising health consciousness among consumers and growing adoption of supplements containing these key omega-3 fatty acids. EPA and DHA are polyunsaturated fatty acids found in marine sources that play an important role in brain and eye health as well as cardiovascular health. Increasing prevalence of lifestyle diseases along with growing aging population has boosted the demand for EPA and DHA supplements. Various clinical studies have demonstrated the far-ranging benefits of EPA and DHA in reducing inflammation, lowering risk of heart disease, and improving neurological functioning. With growing scientific evidence, more people are incorporating these essential fatty acids into their diets through food sources as well as supplements.

Market Dynamics

Increasing consumer awareness about EPA and DHA health benefits and prevalence of chronic diseases boosts sales of EPA and DHA supplements globally. However, high procurement cost of raw materials poses major challenge for market players. Abundant availability of fish oils as well as emergence of alternative vegan sources of omega-3 fatty acids present lucrative opportunities for the market expansion. Sustained R&D into new applications can expand the clinical uses and market outreach of EPA and DHA.

Key Features of the Study

• This report provides in-depth analysis of the global EPA and DHA market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global EPA and DHA market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Herbalife Nutrition Ltd., and Fonterra Co-operative Group Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

• By Source Insights (Revenue, USD Bn, 2020 - 2032)
• Fish Oil
• Algal Oil
• Krill Oil
• Others
• By Form Insights (Revenue, USD Bn, 2020 - 2032)
• Liquid
• Capsules and Soft gels
• Powder
• Others
• By Application Insights (Revenue, USD Bn, 2020 - 2032)
• Dietary Supplements
• Food and Beverages
• Pharmaceuticals
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Koninklijke DSM NV
• KD Pharma Group
• The Archer Daniels Midland Company
• Corbion NV
• Novasep Holding SAS
• Neptune Wellness Solutions
• BASF SE
• Omega Protein Corporation
• Croda International PLC
• Novotech Nutraceuticals
• Herbalife Nutrition Ltd.
• Fonterra Co-operative Group Limited